Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT06757920
NCT06757920CompletedNot Applicable

The Use of Bronchoscopic Argon Plasma Coagulation in Endobronchial Carcinoid

Alexandria University2 sites in 1 country40 target enrollmentStarted: January 1, 2025Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
40
Locations
2
Primary Endpoint
Dyspnea Borg Scale
Study OverviewStudy DesignEligibility CriteriaArms & InterventionsOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

A small tube will go through the respiratory tract and a non contact cauterization will be done to the inside tumor

Detailed Description

fiberoptic bronchoscopy will go through the tracheobronchial tree and after localization of the tumor, argon plasma coagulation by initiation non contact electrocautery will be done to the tumor

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •1 - Cooperative patient with written informed consent. 2- Patients diagnosed with endobronchial carcinoid. 3- Patients fit for fiberoptic bronchoscopy. 4- Patients unwilling or unfit for surgery.

Exclusion Criteria

  • •1 -Poor karnofsky score. 2- Patients unwilling or unfit for bronchoscopy. 3- Extraluminal lesion. 4- Patients with pacemaker. 5- Forced expiratory volume 1 is less than one litre.

Arms & Interventions

fiberoptic bronchoscopy in one group

Active Comparator

fiberoptic bronchoscopic argon plasma coagulation for palliation of endobronchial carc inoid

Intervention: bronchoscopic argon plasma coagulation (Procedure)

Outcomes

Primary Outcomes

Dyspnea Borg Scale

Time Frame: one month

scale from 0 to 4 according to the degree of improvement

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mohamed Sabry

Lecturer of chest diseases

Alexandria University

Study Sites (2)

Loading locations...

Similar Trials

Completed
Phase 1
A Trial to Determine How Long Insulin and FDKP (the Molecule That Forms Technosphere Particles) Stays in the Lungs of Healthy Individuals After Inhalation of Technosphere® Insulin (TI) Powder Using Bronchoalveolar Lavage (BAL)Healthy Subjects
NCT00757367Mannkind Corporation13
Completed
Not Applicable
Sample Collections From the Airways of Asthmatic PatientsAsthma
NCT00001888National Heart, Lung, and Blood Institute (NHLBI)574
Completed
Not Applicable
Segmental Bronchoalveolar LavagePulmonary FibrosisAsthma
NCT00001618National Heart, Lung, and Blood Institute (NHLBI)153
Completed
Phase 1
Feasibility of the modified mini-bronchoalveolar lavage techniques using a nasogastric suction catheter and polytetrafluoroethylene bronchoscopic suction catheter in diagnosing pneumonia: A pilot studyPatient with bilateral pneumonia requiring mechanical ventilationmini-BAL, ventilator associated pneumonia
TCTR20230713011avamindradhiraj University, Bangkok40
Unknown
Not Applicable
NIV-FOB, HFNC-FOB- Comparison of MethodsHypoxemic Respiratory FailureHypoxemiaRespiratory Failure
NCT05655026Medical University of Silesia300